The TBCRC049 Trial for Treating Leptomeningeal Metastases in HER2+ Breast Cancer
December 14, 2019 06:00am
By Adam M. Brufsky, MD, PhD, FACP
Fulvestrant Plus Palbociclib in Breast Cancer
Jun 17, 2016
Joanne Blum, MD, PhD, FACP, physician, Texas Oncology, discusses the combination of fulvestrant and palbociclib (Ibrance) in patients with breast cancer, as well as the synergy fulvestrant has with other CDK4/6 inhibitors.
